How to Evaluate Vendor Access Control Policies

If a vendor can get into your EHR, cloud admin tools, or clinical systems, you need proof that access is limited, logged, reviewed, and shut off on time.

I’d evaluate vendor access control policies by checking four things first: who has access, how they log in, what they can do, and how fast access is removed. In healthcare, that means following a guide to HIPAA-compliant vendor risk management and looking at logical access, remote access, physical access, and non-human identities like API keys, service accounts, and bots. It also means matching each account to a current contract or BAA, testing MFA, reviewing JIT access, checking session logs, and confirming offboarding within 24 hours for normal cases and 2 hours for emergency revocation.

Here’s the short version of what I’d look for:

• A full vendor inventory tied to systems, PHI/ePHI, and named owners
• Risk tiers so high-risk vendors get checked more often
• Named accounts only, not shared vendor logins
• MFA for all remote and admin access
• Least-privilege RBAC instead of broad admin rights
• Time-bound access with approval tickets and expiry records
• Logs for logins, admin actions, and data exports
• Network limits such as bastion hosts, ZTNA, or narrow firewall rules
• PHI controls for viewing, copying, exporting, return, or destruction
• Contract terms and POA&Ms to fix gaps and track due dates

A weak policy usually shows the same red flags: shared accounts, always-on VPNs, poor logging, old service accounts, and no clear link between access and business need. A strong review turns those gaps into evidence-backed findings, contract updates, and a review schedule.

If you want a simple test, ask this: can every vendor action be tied to one account, one approval, and one log trail? If the answer is no, the policy needs work.

Vendor Privileged Access Management overview

sbb-itb-535baee

Step 1: Build Your Vendor Inventory, Risk Tiers, and Evidence Set

Before you score vendor risk, build a complete inventory from your access-path register. The goal is simple: list every entity that can reach your networks, apps, or PHI/ePHI. That includes vendors, contractors, and non-human identities like service accounts, API keys, and bots. Those machine identities often have broad privileges across core systems, so they can't be treated as an afterthought ^[1].

For each vendor record, assign three owners:

• a business sponsor who explains why the access is needed
• a system owner who manages the technical side
• a designated access reviewer ^[1]

Also document every exception. Include an end date, compensating controls, and leadership approval ^[1]. This helps you split normal access from one-off exceptions before you start reviewing controls.

Next, place each vendor into a risk tier based on access sensitivity, privilege level, and patient-impact risk. High-risk vendors should be reviewed monthly when they have admin rights, EHR/EMR access, direct PHI access, or control over clinical devices. Medium-risk vendors with network monitoring access or admin dashboards, but no PHI access, should be reviewed quarterly. Low-risk vendors should be reviewed every six months or at renewal ^[1][3]. High-risk vendors should also have the shortest revocation SLA.

Collect Contracts, BAAs, Policies, and Assessment Evidence

Once your inventory is tiered, gather the records that support each vendor review. Keep the evidence in four groups: contracts and BAAs for legal scope, audit rights, and PHI handling duties ^[4][5]; IAM exports from tools like Azure AD or Okta for guest accounts, service principals, and API keys ^[3][5]; network access records such as VPN settings, firewall rules, and jump-host policies ^[3]; and security artifacts like SOC 2 Type II reports, ISO 27001 certificates, HITRUST letters, or redacted MFA screenshots ^[1][3][5].

"Map access to contractual need and data classification to keep entitlements aligned with business purpose." - Kevin Henry, Accountable ^[1]

Every active vendor identity and service account should tie back to a current contract or BAA. If an account has no match, flag it at once and remove it ^[3][5]. Teams that follow a structured 90-day audit cycle often cut orphaned accounts by 90% ^[4]. You'll use this evidence set in Step 2 to test identity, authentication, and authorization controls.

Standardize Intake with a Healthcare-Focused Assessment Workflow

Use a standard questionnaire and scoring model so each vendor is judged against the same checks: authentication rules, remote access controls, logging, and PHI handling. That makes findings easier to compare and easier to defend during audits.

Skip spreadsheets for this process. They often miss tokens, API keys, and rarely used admin roles, and they fall apart as the vendor list grows ^[1]. This growth often leads to costly and time-consuming assessments for both providers and vendors.

Step 2: Evaluate Identity, Authentication, and Authorization Controls

Now that your vendor inventory is tiered and the evidence is in hand, the job shifts from reading policies to effectively managing third-party risk by checking what happens in practice. That distinction matters. A policy can say all the right things and still fail in day-to-day use.

The main question here is simple: Can every privileged action be tied to a named account? Use the evidence from Step 1 to test enforcement, not policy wording.

Check MFA, Unique IDs, and Non-Human Identity Controls

Start by asking for IdP or gateway logs that show MFA success for administrative and remote sessions. You’ll also want guest-account exports and last-login timestamps tied to named users. Then verify that each account is active and assigned to one person, not passed around by a team.

Non-human identities need the same level of scrutiny. Ask for a full list of service accounts, API keys, and tokens, along with rotation schedules. If a vendor can’t produce that list, treat it as a control failure. It’s a plain warning sign: they may not know what machine access exists, who relies on it, or when it was last updated.

"Implement strict access controls for vendor connections including dedicated accounts, just-in-time access, and session monitoring." - HICP Practice 10.5 ^[2]

Review RBAC, Privileged Access, and Approval Workflows

Use the Third-Party Access Path Register to check each access path, its owner, and its privilege level. This helps you see whether access is tightly scoped or handed out by default. For example, a vendor may have been given broad Domain Admin or Tenant Admin rights when access to one system or one task would have been enough.

For privileged access, look for Just-in-Time (JIT) provisioning. In plain terms, the account should stay disabled until there’s an approved, time-bound maintenance window. Ask for access request tickets that connect a specific change request to elevated rights. Then ask for the matching expiry log. If the access was granted, there should be proof that it ended.

Check Separation of Duties (SoD) rules too. These rules stop one user from holding role combinations that could allow unauthorized system changes. If a vendor support technician can hold conflicting roles that enable unauthorized system changes, mark that as an immediate control gap.

Strong vs. Weak Authorization Practices: A Comparison Table

After that, rate each vendor as strong, mixed, or weak based on the evidence. The table below gives you a quick way to judge where a vendor stands across the controls that matter most.

Use these findings in Step 3 to assess remote access, logging, user lifecycle, and PHI handling.

Step 3: Review Remote Access, Monitoring, User Lifecycle, and Data Handling

Once identity and authorization are mapped, look at the actual routes vendors use to get in, what gets logged, and the rules that govern data use.

Assess Remote Access Paths, Secure Protocols, and Network Segmentation

Start with a full list of vendor access methods: VPN tunnels, RDP sessions, SaaS admin consoles, APIs, gateways, and bastion hosts. For each one, check that MFA is enforced at the entry point, not only in the identity system.

Then review the transport layer. All traffic should use TLS 1.2+ or SSH only. If you find Telnet, FTP, or unencrypted HTTP, flag it right away.

Next, look at scope. Is vendor access limited to only what they need, or does it open a broad path into the network? A wide VPN tunnel makes lateral movement much easier. A better setup uses Zero Trust Network Access (ZTNA) or jump hosts to limit traffic to named systems or APIs.

Ask for firewall rules and network diagrams that show how vendor traffic is separated from clinical and corporate segments. If those diagrams don’t exist, that’s a gap. Once the path is clear, confirm that it’s logged and restricted to the minimum set of reachable systems.

Verify Logging, Access Reviews, Offboarding, and PHI Handling Restrictions

After that, test whether vendor activity can be traced from start to finish.

Ask for SIEM exports or raw log snippets that show successful and failed logins, privilege escalations, and data exports. You also need to confirm that log retention meets your forensic and regulatory needs. Audit logs for sessions involving PHI should be kept for at least 12 months, and some contracts or rules may require retention for up to 6 years ^[4].

The riskiest moments in the vendor lifecycle usually come during offboarding and access changes. For offboarding, ask for HR or contract termination tickets and match them against IAM deprovisioning timestamps. The target should be 24 hours for standard offboarding and 2 hours for emergency revocation ^[4]. When a user’s scope changes, compare before-and-after entitlements to make sure old access was removed instead of left hanging around.

Then review how the vendor can handle PHI. The BAA should spell out what data is allowed, how it must be handled, and what happens to it at contract end, whether that means destruction or return. On the technical side, ask for DLP logs or system configuration screenshots that show download and export functions are restricted for vendor accounts.

If a vendor can copy or transfer PHI freely, with no logging and no limits, that’s a critical finding no matter how strong the rest of the control set looks.

Controls-to-Evidence Mapping Table

Use this table to map controls to evidence.

Step 4: Convert Findings into Contract Requirements, Remediation, and Ongoing Oversight

Once you've mapped the evidence and logged the gaps, the next move is simple: turn each finding into contract terms, remediation work, and oversight.

Write Minimum Access Control Requirements into Contracts and BAAs

Every vendor account should tie back to a specific contract entry. If that link doesn't exist, enforcing controls gets messy fast. It also makes it much harder to push noncompliance to legal and procurement.

When you update contracts and BAAs, spell out these baseline requirements:

For high-risk vendors, these terms should be the floor, not the ceiling. If you need interim controls right away, use that remediation evidence to support formal contract updates at the next renewal cycle ^[3]. That way, failed controls don't just sit in a report. They become items procurement and legal can act on during renewal talks.

Track Remediation with POA&Ms and Recurring Reassessments

After the contract terms are in place, assign every open gap to a POA&M. Each one should have:

• one owner
• one due date
• one mitigation path

Keep it tight and concrete. High-risk findings like shared credentials, unlogged privileged sessions, and missing MFA on EMR access should be closed within 24 to 72 hours ^[3][4]. If there's an active compromised account, treat it as an emergency and revoke access within 2 hours ^[4].

Sometimes a vendor drags their feet or won't cooperate. That's not just a process issue. It's a contract risk. This friction often stems from the economic impact of third-party risk management in healthcare, where inefficient processes drive up costs. Escalate it to legal and procurement, put compensating controls in place like network segmentation, and document the issue. A documented refusal should also trigger review for emergency contract termination ^[3].

Conclusion: What a Sound Vendor Access Control Evaluation Should Produce

A finished evaluation should give you five concrete outputs: a current vendor inventory with risk tiers, evidence-backed control findings, updated contracts and BAAs with enforceable clauses, active POA&Ms with assigned owners, and a clear oversight schedule.

For ongoing monitoring, track:

• access review completion frequency
• remote session activity anomalies
• MFA coverage rates, with a target of 95%+ for critical vendors ^[5]

Review timing should match vendor risk. High-risk vendors need monthly reviews. Moderate-risk vendors should be reviewed quarterly. Low-risk vendors can be reviewed biannually or annually. You should also trigger out-of-cycle reviews right after any security incident, contract change, organizational restructure, or discovery of shared or long-lived credentials ^[3][1]. Used on a steady basis, this process supports HIPAA compliance and cuts third-party vendor security risks.

FAQs

What evidence should I request from a vendor first?

Start with the documents that show the vendor’s security posture: security policies, compliance certifications, and technical configuration details.

If the vendor handles protected health information, ask for a Business Associate Agreement (BAA), proof of multi-factor authentication, and role and permission mappings to confirm least-privilege access. Censinet RiskOps can help streamline the collection and review of this documentation.

How can I verify vendor access is removed on time?

Use automated deprovisioning and validation instead of manual tracking. Set clear offboarding SLAs, with access removal usually due within 24 to 72 hours of contract termination or staff changes.

When those events happen, disable accounts, rotate secrets, and revoke API keys. Then confirm the removal by re-running log queries or system audits, and attach that evidence to a formal remediation ticket.

How often should high-risk vendors be reviewed?

High-risk vendors should be reviewed at least monthly to make sure their access is still appropriate. Some standards point to quarterly revalidation for general long-term vendor access, but high-risk vendors need closer attention.

Each review should confirm least-privilege access and check that permissions still line up with current business needs and contract terms. Platforms like Censinet RiskOps™ can help make these assessments easier and give teams continuous visibility into third-party risk.

Related Blog Posts

• How to Secure Vendor Access in Clinical Applications
• Ultimate Guide to Third-Party Access Control in Healthcare
• Best Practices for Vendor Communication Security
• How to Assess Cloud Vendor Access Control in Healthcare